This grant supports investigator-initiated clinical trials in arthritis, musculoskeletal, or skin diseases, funding both trial preparation and implementation for studies ready to begin.
Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.
This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.